Filtros de búsqueda

Lista de obras de Linda T Vahdat

A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors

artículo científico publicado en 1999

A phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma.

artículo científico publicado en 2003

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

artículo científico publicado en 2018

Abstract 4184: Development of ixabepilone-induced CIPN is related to pre-treatment with paclitaxel in a mouse model

article

Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche.

artículo científico publicado en 2015

Allogeneic Stem Cell Transplantation for Breast Cancer

Allogeneic Stem Cell Transplantation for Breast Cancer

An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis.

artículo científico publicado en 2017

Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes

artículo científico publicado en 2010

Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis.

artículo científico publicado en 2009

Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy

scientific article published on 01 September 2007

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial

scientific article published on 26 April 2018

Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression.

artículo científico publicado en 2009

Breast cancer methylomes establish an epigenomic foundation for metastasis

artículo científico publicado en 2011

Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group.

artículo científico publicado en 2012

BreastPRS is a gene expression assay that stratifies intermediate-risk Oncotype DX patients into high- or low-risk for disease recurrence.

artículo científico publicado en 2013

CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer

scientific article published on 01 August 1999

Carboplatin and etoposide in metastatic breast cancer

scientific article published on 01 April 1995

Chemotherapy-Induced Palmar-Plantar Erythrodysesthesia Syndrome: Etiology and Emerging Therapies

artículo científico publicado en 2004

Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies

artículo científico publicado en 2004

Choosing a taxane for adjuvant treatment of breast cancer: more than a flip of the coin?

artículo científico publicado en 2008

Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

artículo científico publicado en 2007

Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2005

Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2009

Clinical benefit, toxicity and cost of metastatic breast cancer therapies: systematic review and meta-analysis

scientific article published on 14 May 2019

Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2006

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2007

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

artículo científico publicado en 2008

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurrent or metastatic breast cancer: results from a Phase II, single-arm,

scientific article published on 07 December 2016

Clinical response to eribulin in patients with metastatic breast cancer is independent of time to first metastatic event. EMBRACE study group

Clinical studies with epothilones for the treatment of metastatic breast cancer

artículo científico publicado en 2008

Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic grafts

scientific article published on 01 October 1996

Copper Depletion as a Therapeutic Strategy in Cancer

scientific article published on 01 January 2019

Copper suppression as cancer therapy: the rationale for copper chelating agents in BRAFV600 mutated melanoma

artículo científico publicado en 2016

Correction: Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

scientific article published on 01 September 2020

Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse

artículo científico publicado en 2005

Dasatinib plus capecitabine for advanced breast cancer: safety and efficacy in phase I study CA180004.

artículo científico publicado en 2013

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

artículo científico publicado en 2020

Dermatological toxicity of ixabepilone.

artículo científico publicado en 2006

Disease-free survival according to the use of postmastectomy radiation therapy after neoadjuvant chemotherapy.

artículo científico publicado en 2014

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer

artículo científico publicado en 2015

Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer

artículo científico

Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials

scientific article published on 04 August 2018

Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine

artículo científico publicado en 2007

Efficacy and safety of ixabepilone plus capecitabine in elderly patients with anthracycline- and taxane-pretreated metastatic breast cancer

artículo científico publicado en 2013

Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy

artículo científico publicado en 2015

Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

artículo científico publicado en 2014

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.

artículo científico publicado en 2017

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

artículo científico publicado en 2015

Epothilones: clinical update and future directions.

scientific article published on April 2008

Eribulin Mesylate ⬇️

artículo científico publicado el 22 de agosto de 2011

Eribulin mesylate for the treatment of breast cancer.

artículo científico publicado en 2010

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.

artículo científico publicado en 2013

Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancer

artículo científico publicado en 2014

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.

artículo científico publicado en 2011

Erratum to: Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies

artículo científico publicado en 2015

Erratum to: Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.

artículo científico publicado en 2014

Erythema nodosum secondary to aromatase inhibitor use in breast cancer patients: case reports and review of the literature.

artículo científico publicado en 2007

First-in-Human Trial of a Novel Anti-Trop-2 Antibody-SN-38 Conjugate, Sacituzumab Govitecan, for the Treatment of Diverse Metastatic Solid Tumors

artículo científico publicado en 2015

Functional Peptide Nanofibers with Unique Tumor Targeting and Enzyme-Induced Local Retention Properties

artículo científico publicado en 2018

Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study

artículo científico publicado en 2005

Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.

artículo científico publicado en 2016

Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support

scientific article published on 01 February 1997

Health-related quality of life in patients receiving first-line eribulin mesylate with or without trastuzumab for locally recurrent or metastatic breast cancer.

artículo científico publicado en 2019

High-Grade KIT-Negative Sarcoma of the Small Bowel in a Patient With Chronic Myeloid Leukemia Receiving Long-Term Tyrosine Kinase Inhibitors ⬇️

artículo científico publicado el 25 de febrero de 2013

High-dose chemotherapy of breast cancer: Current status and developmental strategies ⬇️

artículo científico publicado el 1 de enero de 1995

High-dose chemotherapy of metastatic breast cancer: a review

artículo científico publicado en 1995

High-dose chemotherapy with autologous stem cell support for breast cancer

artículo científico publicado en 1997

High-dose therapy for breast cancer.

artículo científico publicado en 1995

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.

artículo científico publicado en 1998

High-intensity chemotherapy with hematopoietic support in breast cancer

artículo científico publicado en 1993

Impact of prior anthracycline or taxane use on eribulin effectiveness as first-line treatment for metastatic breast cancer: results from two phase 2, multicenter, single-arm studies

artículo científico publicado en 2015

Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients ⬇️

artículo científico publicado el 9 de diciembre de 2011

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases.

artículo científico publicado en 2016

Inhibition of EZH2 Catalytic Activity Selectively Targets a Metastatic Subpopulation in Triple-Negative Breast Cancer

scientific article published on 01 January 2020

Integrating epothilones into the treatment of patients with metastatic breast cancer: clinical perspectives on incorporating recent data in the practice setting

artículo científico publicado en 2008

Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer

artículo científico publicado en 2019

Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device

artículo científico publicado en 2013

Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment of metastatic breast cancer

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment

artículo científico publicado en 2007

Ixabepilone plus capecitabine in advanced breast cancer patients with early relapse after adjuvant anthracyclines and taxanes: a pooled subset analysis of two phase III studies

artículo científico

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

artículo científico publicado en 2012

Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients

artículo científico publicado en 2014

Ixabepilone: a novel antineoplastic agent with low susceptibility to multiple tumor resistance mechanisms

scientific article published on March 2008

Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials

artículo científico publicado en 2012

Measuring the impact of chemotherapy on fertility in women with breast cancer

artículo científico publicado en 2006

Menopause is a determinant of breast adipose inflammation

artículo científico publicado en 2015

Microenvironmental regulation of epithelial-mesenchymal transitions in cancer ⬇️

artículo científico publicado el 20 de septiembre de 2012

Microtubule-Stabilizing Agent: Halichondrin B Analog (E7389)

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy

scientific article published on 21 September 2018

Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition ⬇️

artículo científico publicado el 26 de enero de 2012

New developments in metastatic breast cancer: general discussion

artículo científico publicado en 2013

New developments in metastatic breast cancer: integrating recent data into clinical practice

artículo científico publicado en 2013

Novel combinations for the treatment of metastatic breast cancer

artículo científico publicado en 2010

Novel data in metastatic breast cancer

artículo científico publicado en 2013

Novel treatment options in the management of metastatic breast cancer.

scientific article published on May 2011

Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis.

artículo científico publicado en 2015

Personalized Nutrition in Disrupting Cancer - Proceedings From the 2017 American College of Nutrition Annual Meeting

artículo científico publicado en 2018

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer.

artículo científico publicado en 2014

Phase 2, multicenter, single-arm study of eribulin mesylate with trastuzumab as first-line therapy for locally recurrent or metastatic HER2-positive breast cancer.

artículo científico publicado en 2014

Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation.

artículo científico publicado en 1998

Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer.

artículo científico publicado en 1998

Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

scientific article published on 26 September 2013

Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer

artículo científico publicado en 2008

Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer

artículo científico publicado en 2006

Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.

artículo científico publicado en 2014

Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast Cancer

artículo científico publicado en 2007

Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, as first-line therapy in patients with metastatic breast cancer previously treated with anthracycline chemotherapy

artículo científico publicado en 2007

Phase II study evaluating the efficacy and safety of sagopilone (ZK-EPO) in patients with metastatic breast cancer that has progressed following chemotherapy

artículo científico publicado en 2010

Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane

artículo científico publicado en 2009

Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine

scientific article published on 02 August 2010

Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer

artículo científico publicado en 2002

Phase II trial of tipifarnib plus neoadjuvant doxorubicin-cyclophosphamide in patients with clinical stage IIB-IIIC breast cancer

artículo científico publicado en 2009

Phase III trials of eribulin mesylate (E7389) in extensively pretreated patients with locally recurrent or metastatic breast cancer

artículo científico publicado en 2010

Prevention of chemotherapy and radiation toxicity with glutamine.

artículo científico publicado en 2003

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

artículo científico publicado en 2015

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer

artículo científico publicado en 2017

Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer

artículo científico publicado en 2001

Randomized trial of low-dose interleukin-2 vs cyclosporine A and interferon-γ after high-dose chemotherapy with peripheral blood progenitor support in women with high-risk primary breast cancer

artículo científico publicado en 2007

Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer

artículo científico publicado en 1993

Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancer

artículo científico publicado en 1995

Reduction of paclitaxel-induced peripheral neuropathy with glutamine

artículo científico publicado en 2001

Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study

Remodeling of the methylation landscape in breast cancer metastasis.

artículo científico publicado en 2014

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

artículo científico publicado en 2019

Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics

artículo científico publicado en 2017

Sacituzumab govitecan: an antibody-drug conjugate

artículo científico

Smart Nanotransformers with Unique Enzyme-Inducible Structural Changes and Drug Release Properties

artículo científico publicado en 2016

Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration.

artículo científico publicado en 2013

Systemic adjuvant therapy of breast cancer

artículo científico publicado en 1997

Targeted Therapy For Breast Cancer

Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide

scientific article published on 12 June 2006

The effect of a contemplative self-healing program on quality of life in women with breast and gynecologic cancers

artículo científico publicado en 2010

The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m2 continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer

artículo científico publicado en 2001

The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma

artículo científico publicado en 2007

The use of an antibody drug conjugate, glembatumumab vedotin (CDX-011), for the treatment of breast cancer

artículo científico

Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer

artículo científico publicado en 2002

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda